INVO Fertility, Inc. last reported quarterly results on Aug 17, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $2.2 million (+16.7% year over year) and diluted EPS of $0.35. It usually reports 46–63 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 16, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Monday. Based on last year's release for the same quarter on Nov 17, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 46–63 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 17, 2026
48 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
2
+16.7%
|
1
+124.6%
|
0.35
+100.1%
|
|
Jun 2, 2026
63 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
2
+23.1%
|
-6
+68.2%
|
-3.38
+99.9%
|
|
Nov 17, 2025
48 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
2
+22.6%
|
-3
-108.2%
|
-39.40
-160.8%
|
|
Aug 15, 2025
46 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
2
+1.5%
|
-4
-61.2%
|
-364.23
-1526.8%
|
|
Apr 30, 2025
30 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
2
+3.9%
|
-17
-990.1%
|
-3,473.93
-45912.3%
|
|
Aug 14, 2024
45 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
Apr 16, 2024
16 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Nov 13, 2023
44 days after quarter end
|
—
ended Sep 30, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.